We and others have shown that trisomy of DYRK1A contributes to the development of both ML-DS and DS-ALL, and that inhibition of its kinase activity or of its targets (STAT3, FOXO1, Cyclin D3) decreases growth and survival in vitro and prolongs in vivo survival [165,190]. Here, DYRK1A is linked to Dravet syndrome.